Tollenaar RAEM - Search Results

1

Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

Giardiello D, Hauptmann M, Steyerberg EW, Adank MA, Akdeniz D, Blom JC, Blomqvist C, Bojesen SE, Bolla MK, Brinkhuis M, Chang-Claude J, Czene K, Devilee P, Dunning AM, Easton DF, Eccles DM, Fasching PA, Figueroa J, Flyger H, García-Closas M, Haeberle L, Haiman CA, Hall P, Hamann U, Hopper JL, Jager A, Jakubowska A, Jung A, Keeman R, Koppert LB, Kramer I, Lambrechts D, Le Marchand L, Lindblom A, Lubiński J, Manoochehri M, Mariani L, Nevanlinna H, Oldenburg HSA, Pelders S, Pharoah PDP, Shah M, Siesling S, Smit VTHBM, Southey MC, Tapper WJ, Tollenaar RAEM, van den Broek AJ, van Deurzen CHM, van Leeuwen FE, van Ongeval C, Van't Veer LJ, Wang Q, Wendt C, Westenend PJ, Hooning MJ, Schmidt MK. Giardiello D, et al. Among authors: tollenaar raem. Breast Cancer Res Treat. 2020 Jun;181(2):423-434. doi: 10.1007/s10549-020-05611-8. Epub 2020 Apr 11. Breast Cancer Res Treat. 2020. PMID: 32279280 Free PMC article.

2

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.

Papelard H, de Bock GH, van Eijk R, Vliet Vlieland TP, Cornelisse CJ, Devilee P, Tollenaar RA. Papelard H, et al. Br J Cancer. 2000 Sep;83(6):719-24. doi: 10.1054/bjoc.2000.1331. Br J Cancer. 2000. PMID: 10952774 Free PMC article.

3

[From gene to disease; from BRCA1 or BRCA2 to breast cancer].

Devilee P, Tollenaar RA, Cornelisse CJ. Devilee P, et al. Ned Tijdschr Geneeskd. 2000 Dec 30;144(53):2549-51. Ned Tijdschr Geneeskd. 2000. PMID: 11191790 Review. Dutch.

4

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.

de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

5

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

6

[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy].

Schmidt MK, van Leeuwen FE, Klaren HM, Tollenaar RA, van 't Veer LJ. Schmidt MK, et al. Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):564-8. Ned Tijdschr Geneeskd. 2004. PMID: 15074178 Review. Dutch.

7

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.

de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. J Med Genet. 2004 Oct;41(10):731-5. doi: 10.1136/jmg.2004.019737. J Med Genet. 2004. PMID: 15466005 Free PMC article.

8

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

9

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.

Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, Tilanus-Linthorst MM, Seynaeve C, Bartels CC, Kaas R, Meijer S, Oosterwijk JC, Hoogerbrugge N, Tollenaar RA, Rutgers EJ, de Koning HJ, Klijn JG. Kriege M, et al. Breast Cancer Res Treat. 2006 Nov;100(1):109-19. doi: 10.1007/s10549-006-9230-z. Epub 2006 Jun 22. Breast Cancer Res Treat. 2006. PMID: 16791481

10

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters